市場調査レポート

商品コード

1084760

凍結乾燥薬の市場規模・シェア・動向・予測 (2022年～2028年)：薬剤クラス・適応症・包装タイプ・地域別

Lyophilized Drugs Market, by Drug Class, by Indication, by Packaging Type, and by region - Size, Share, Trends, and Forecast, 2022 - 2028

出版日: 2022年05月16日 | 発行: Coherent Market Insights

| ページ情報: 英文 208 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 701,325円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,090,950円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,558,500円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.85円

全表示
概要
目次

概要

サンプル依頼リストに入れる

感染症の流行が増加しており、世界の凍結乾燥薬市場の成長を助けると予想されています。また、製造業者は凍結乾燥剤の大規模製造に向けた設備の拡張に前向きであり、このことも同市場の成長に寄与しています。

当レポートでは、世界の凍結乾燥薬の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

ヒートマップ分析
企業プロファイル
- Sanofi SA
- Merck &Co., Inc.
- Fresenius Kabi USA, LLC.
- Ciron Drugs &Pharmaceuticals Pvt Ltd.
- GlaxoSmithKline plc.
- Mylan NV.
- Pfizer, Inc.
- Amneal Pharmaceuticals LLC
- Otsuka Holdings Co., Ltd.(Otsuka Pharmaceutical Co., Ltd.)
- BTG Plc.
アナリストの見解

第9章セクション

Product Code: CMI2930

Lyophilization or freeze drying is the process, in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a liquid phase. The process includes three steps: Freezing, primary drying (sublimation), and secondary drying (desorption). Pharmaceutical products that undergo lyophilization process include bulk pharmaceutical/biopharmaceutical ingredient (API), protein, collagen, peptide, oligonucleotide, enzymes, and mAbs.

Market Dynamics

Lyophilized drugs are majorly used to treat infectious diseases and autoimmune diseases. Thus, increasing prevalence of infectious diseases is expected to aid in growth of the global lyophilized drugs market. For instance, according to The Lancet Infectious Diseases (report) published in 2021, fungal infection affects over a billion people worldwide, resulting in around 11.5 million life-threatening infections and over 1.5 million deaths, annually. The number of lyophilized drugs such as Amphotericin B (Mycoflu), Vonfung NDD (voriconazole,) and other antifungal lyophilized drugs are available in market for treating fungal infections.

Lyophilized drug manufacturers are looking forward to expand their facilities to produce lyophilized drugs on large scale, which in turn contributing to growth of the global lyophilized drugs market. For instance, on January 2021, AB Technologies (AB) announced investment of US$ 10.5 million to build a new 23,000-square-foot manufacturing facility at its site in Bloomington, Indiana. The new facility will include manufacturing area for formulating, filling, lyophilizing, and packaging drugs for early-phase clinical trial studies. Moreover, AB Technologies (AB) added aseptic filling and lyophilizer loading systems into the new facility.

Major pharmaceutical manufacturers are engaged in the development and launching of innovative lyophilized drugs, which is expected to drive the global lyophilized drugs market growth. For instance, in November 2018, Xellia Pharmaceuticals launched Vancomycin Hydrochloride for Injection, USP within the U.S. market. Vancomycin Hydrochloride for Injection is lyophilized powder to treat or prevent infections that are caused by bacteria

Key features of the study:

This report provides in-depth analysis of the global lyophilized drugs market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global lyophilized drugs market based on the following parameters - company overview, financial performance, Technology portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Sanofi S.A, Merck & Co., Inc., Fresenius Kabi USA, LLC., Ciron Drugs & Pharmaceuticals Pvt Ltd., GlaxoSmithKline plc., Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.), and BTG Plc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future technology launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global lyophilized drugs market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global Lyophilized Drugs Market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Lyophilized Drugs Market, By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
Global Lyophilized Drugs Market, By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
Global Lyophilized Drugs Market, By Packaging Type:
- Vial
- Injection
- Cartridge
Global Lyophilized Drugs Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
  - By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
  - By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
  - By Packaging Type:
- Vial
- Injection
- Cartridge
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
  - By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
  - By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
  - By Packaging Type:
- Vial
- Injection
- Cartridge
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
  - By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
  - By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
  - By Packaging Type:
- Vial
- Injection
- Cartridge
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
  - By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
  - By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
  - By Packaging Type:
- Vial
- Injection
- Cartridge
- Middle East
  - By Country/Region:
- GCC
- Israel
- Rest of Middle East
  - By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
  - By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
  - By Packaging Type:
- Vial
- Injection
- Cartridge
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
  - By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
  - By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
  - By Packaging Type:
- Vial
- Injection
- Cartridge
Company Profiles
- Sanofi S.A *
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Merck & Co., Inc.
- Fresenius Kabi USA, LLC.
- Ciron Drugs & Pharmaceuticals Pvt Ltd.
- GlaxoSmithKline plc.
- Mylan NV.
- Pfizer, Inc.
- Amneal Pharmaceuticals LLC
- Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
- BTG Plc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Indication
- Market Snippet, By Packaging Type
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technology Advancements
Historical Overview
Merger and Acquisition
Regulatory Scenario
PORTER'S Five Forces
PEST Analysis

4. Global Lyophilized Drugs Market, By Drug Class, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Antineoplastic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Proton Pump Inhibitor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Anesthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Anticoagulant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
NSAID's
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Lyophilized Drugs Market, By Indication, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Autoimmune Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Gastrointestinal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Lyophilized Drugs Market, By Packaging Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Cartridge
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Lyophilized Drugs Market, By Region, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- Northern Africa
- Central Africa
- South Africa

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- Sanofi S.A.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co., Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Fresenius Kabi USA, LLC.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ciron Drugs & Pharmaceuticals Pvt Ltd.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Mylan NV.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Amneal Pharmaceuticals LLC
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BTG Plc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

凍結乾燥薬の市場規模・シェア・動向・予測 (2022年～2028年)：薬剤クラス・適応症・包装タイプ・地域別

Lyophilized Drugs Market, by Drug Class, by Indication, by Packaging Type, and by region - Size, Share, Trends, and Forecast, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・法規制・動向分析

第4章世界の凍結乾燥薬市場：薬剤クラス別

第5章世界の凍結乾燥薬市場：適応症別

第6章世界の凍結乾燥薬市場：包装タイプ別

第7章世界の凍結乾燥薬市場：地域別

第8章競合情勢

第9章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Lyophilized Drugs Market, By Drug Class, 2017 - 2028, (US$ Million)

5. Global Lyophilized Drugs Market, By Indication, 2017 - 2028, (US$ Million)

6. Global Lyophilized Drugs Market, By Packaging Type, 2017 - 2028, (US$ Million)

7. Global Lyophilized Drugs Market, By Region, 2017 - 2028, (US$ Million)

8. Competitive Landscape

9. Section

凍結乾燥薬の市場規模・シェア・動向・予測 (2022年～2028年)：薬剤クラス・適応症・包装タイプ・地域別

Lyophilized Drugs Market, by Drug Class, by Indication, by Packaging Type, and by region - Size, Share, Trends, and Forecast, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・法規制・動向分析

第4章 世界の凍結乾燥薬市場：薬剤クラス別

第5章 世界の凍結乾燥薬市場：適応症別

第6章 世界の凍結乾燥薬市場：包装タイプ別

第7章 世界の凍結乾燥薬市場：地域別

第8章 競合情勢

第9章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Lyophilized Drugs Market, By Drug Class, 2017 - 2028, (US$ Million)

5. Global Lyophilized Drugs Market, By Indication, 2017 - 2028, (US$ Million)

6. Global Lyophilized Drugs Market, By Packaging Type, 2017 - 2028, (US$ Million)

7. Global Lyophilized Drugs Market, By Region, 2017 - 2028, (US$ Million)

8. Competitive Landscape

9. Section

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・法規制・動向分析

第4章世界の凍結乾燥薬市場：薬剤クラス別

第5章世界の凍結乾燥薬市場：適応症別

第6章世界の凍結乾燥薬市場：包装タイプ別

第7章世界の凍結乾燥薬市場：地域別

第8章競合情勢

第9章セクション